Jordan Graybill, MD
Interventional Pain Medicine · Vancouver, WANPI 1053585802
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $941 of the $1,497 with a category attached, or 62.9%. 9 manufacturers reported payments, led by Si-bone, Inc. at 37.1% of the total. Reporting peaked in 2024 at $760 and has fallen 68.8% since, to $237 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in WA, where the typical reported total is $2,704.
Across 29 payments — averaging $51.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$556
- Abbott$316
- Boston Scientific$232
- Pacira Pharmaceuticals Incorporated$203
- Nevro Corp.$96
- AbbVie$40
- plus $55 from 3 others
What the payments were for
- Travel & lodging$55637%
- Food & beverage$94163%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 1 | $556 |
| Abbott | 7 | $316 |
| Boston Scientific | 6 | $232 |
| Pacira Pharmaceuticals Incorporated | 6 | $203 |
| Nevro Corp. | 3 | $96 |
| AbbVie | 2 | $40 |
| Biodelivery Sciences International, Inc. | 2 | $29 |
| Medtronic | 1 | $13 |
| Indivior Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$556
- PROCLAIM$155
How this compares
$1,497 in reported general payments places this provider in the 40th percentile of 30 interventional pain medicine providers in Washington.
See all interventional pain medicine providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 14 | $15,992 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 142 | $13,253 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 321 | $5,426 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 121 | $3,864 |
| Gabapentin | 202 | $2,904 |
| Oxycodone Hcl | 184 | $2,671 |
| Lidocaine | 14 | $1,489 |
| Topiramate | 81 | $1,335 |
| Buprenorphine Hcl | 40 | $1,293 |
| Hydromorphone Hcl | 51 | $1,275 |
| Pregabalin | 96 | $1,019 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 31 | $898 |
| Etodolac | 12 | $886 |
| Baclofen | 109 | $786 |
| Methocarbamol | 36 | $777 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Vancouver
- Ray BakerKirkland$1.2M
- Daniel NelsonKirkland$29K
- Kyong KimLakewood$23K
- Hyun HongOlympia$16K
- Glen DavidSeattle$14K
- Kiang Yien CheungTacoma$12K
- Diyan RazaSeattle$12K
- Kathy WangPuyallup$11K
- Allen ShohamRichland$8K
- Kashif SaeedTacoma$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.